Rationale and design of a prospective, observational, multicentre study on the safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR study

Rationale and design of a prospective, observational, multicentre study on the safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR study

Introduction The risk for stroke in adults with congenital heart disease (ACHD) is increased, especially in the setting of commonly ensuing atrial arrhythmias (AA), namely atrial fibrillation, atrial flutter or intra-atrial re-entrant tachycardia. Data are limited regarding treatment with non-vitami...

Full description

Saved in:
Bibliographic Details
Main Authors: Despoina Ntiloudi, Sotiria Apostolopoulou, Alexandra Frogoudaki, Haralambos Karvounis, George Giannakoulas, Anastasios Kartas, Ioannis Doundoulakis, Athanasios Koutsakis, Diamantis Kosmidis, Georgios Rampidis, Afrodite Tzifa, Dimosthenis Avramidis, Olga Ntzoyvara, Sotiria Liori, Tereza Mousiama, Sophia Anastasia Mouratoglou
Format: Article
Language:English
Published: BMJ Publishing Group 2020-09-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/9/e038012.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/10/9/e038012.full

Similar Items